Discovery and Hit to Lead Optimization of Novel Combretastatin A-4 Analogues: Dependence of C-Linker Length and Hybridization

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|13|10|1614-1635

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.13, Iss.10, 2013-12, pp. : 1614-1635

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel cis-restricted β-lactam combretastatin A-4 analogues display anti-vascular and anti-metastatic properties in vitro

By                

Oncology Reports, Vol. 29, Iss. 2, 2013-01 ,pp. : 585-594

Spandidos Publications

Access to resources Recommend Favorite

Combretastatin A4 phosphate: a novel vascular disrupting agent

By Nagaiah Govardhanan   Remick Scot C  

Future Oncology, Vol. 6, Iss. 8, 2010-08 ,pp. : 1219-1228

Future Medicine

Access to resources Recommend Favorite

Synthesis and Antiproliferative Effects of 5,6-Disubstituted Pyridazin-3(2H)-ones Designed as Conformationally Constrained Combretastatin A-4 Analogues

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 7, 2013-09 ,pp. : 1133-1140

Bentham Science Publishers

Access to resources Recommend Favorite

Combretazet-3 a novel synthetic cis-stable combretastatin A-4-azetidinone hybrid with enhanced stability and therapeutic efficacy in colon cancer

By                

Oncology Reports, Vol. 29, Iss. 6, 2013-01 ,pp. : 2451-2458

Spandidos Publications

Access to resources Recommend Favorite

Synthesis of Combretastatin A-4 Analogs and their Biological Activities

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 8, 2016-07 ,pp. : 942-960

Bentham Science Publishers

Access to resources Recommend Favorite